Diabetes Complications
📧 Sign up to get email alerts when something new happens for Diabetes Complications.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-18EMA Authorised: Vislyfa (ranibizumab) — Lupin Europe GmbH
The EMA has authorised Vislyfa (ranibizumab) by Lupin Europe GmbH for multiple retinal and diabetic eye diseases, expanding access to this a…
-
EMA approval · 2026-08-03EMA Authorised: Vabysmo (Faricimab) — Roche Registration GmbH
EMA authorises Vabysmo (faricimab) for wet macular degeneration, macular edema, and diabetes-related eye complications.
-
EMA approval · 2026-07-01EMA Authorised: Eydenzelt (aflibercept) — Celltrion Healthcare Hungary Kft.
EMA authorised Eydenzelt (aflibercept) for multiple ophthalmic conditions including wet age-related macular degeneration, macular edema, and…
-
EMA approval · 2026-06-16EMA Authorised: Eydenzelt (aflibercept) — Celltrion Healthcare Hungary Kft.
EMA authorised Eydenzelt (aflibercept) by Celltrion Healthcare Hungary Kft. for multiple retinal diseases including wet age-related macular …
-
EMA approval · 2026-06-15EMA Authorised: Rimmyrah (ranibizumab) — Qilu Pharma Spain S.L.
The EMA authorises Rimmyrah (ranibizumab) by Qilu Pharma Spain S.L. for multiple ophthalmic indications including wet age-related macular de…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Thai PainPREDICT Validation Study [NA]
ClinicalTrials.gov listing for the Thai PainPREDICT Validation Study, a recruiting trial evaluating PainPREDICT in patients with painful dia…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Characteristics of Diabetic Foot Ulcer Patients
A clinical trial update describing the baseline characteristics of patients with diabetic foot ulcers. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. [Phase 4]
A decentralized N=1 trial evaluates individual response to dapagliflozin in type 2 diabetes patients, completed phase 4.
-
EMA approval · 2024-03-26EMA Authorised: Ximluci (ranibizumab) — STADA Arzneimittel AG
European Medicines Agency authorised Ximluci (ranibizumab) for indications including wet age-related macular degeneration, macular edema, an…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: CeraVe Diabetes Mellitus [Phase 4]
Phase 4 clinical trial completed; results posted for CeraVe Diabetes Mellitus study.
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy
Clinical trial update on glial pathways to hypoglycemia-associated autonomic failure (HAAF) in humans using carbon-13 magnetic resonance spe…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating zoledronic acid versus methylprednisolone for active Charcot arthropathy in diabetic patients has comple…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Abnormal Plantar Pressure in Patients With Diabetes
A completed clinical trial investigating abnormal plantar pressure in patients with diabetes; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Development and Testing of a New Generation of Diabetic Footwear [NA]
A completed clinical trial on a new generation of diabetic footwear with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Lipid Biomarkers for Diabetic Heart Disease [NA]
A completed clinical trial studying lipid biomarkers in diabetic heart disease; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function [Phase 4]
Phase 4 trial investigating the effects of liraglutide on bone turnover, bone mass, and bone cell function in patients with diabetes complic…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: The Effects of Empagliflozin on Arterial Wall Characteristics [Phase 4]
Phase 4 trial investigating the effects of empagliflozin on arterial wall characteristics in individuals with vascular stiffness and diabete…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community [Phase 3]
A Phase 3 pilot trial evaluated health coaching to promote diabetes self-care in the community and has completed.